journal article

Efficacy of vemurafenib in BRAFV600K mutation positive melanoma disease - results from the phase III clinical study BRIM-3.

Authors
Publication date
1 January 2011
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The University of Manchester - Institutional Repository

    redirect
    oaioai:pure.atira.dk:openaire_cri...
    Last time updated on 09/10/2025